Home › Pill Identifier › WATSON 3159
Print Save or Share

WATSON 3159

Pill imprint WATSON 3159 has been identified as Ursodiol 300 mg.

Ursodiol is used in the treatment of gallbladder disease; biliary cirrhosis; nonalcoholic fatty liver disease and belongs to the drug class gallstone solubilizing agents. There is no proven risk in humans during pregnancy.

Ursodiol 300 mg is not subject to the Controlled Substances Act.
See also related documents.

Ursodiol Images

Ursodiol
Imprint:
WATSON
3159
Strength:
300 mg
Color:
White
Size:
22.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Inactive Ingredients:
silicon dioxide colloidal
ferric oxide
gelatin
magnesium stearate
corn starch
ferrosoferric oxide
Drug Class:
Gallstone solubilizing agents
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals
National Drug Code (NDC):
00591-3159
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0213 Amerisource Health Services

Note: Inactive ingredients may vary.

View Drug DetailsPrint Page

Ursodiol 300 mg WATSON 3159 Front
Ursodiol 300 mg WATSON 3159 Back
Ursodiol 300 mg WATSON 3159
Ursodiol 300 mg WATSON 3159
Advertisement

More Ursodiol resources

Ursodiol is associated with the treatment of:

Search Again

Search by Imprint, Shape or Color

Note: All fields optional. Use the pill finder to identify medications by visual appearance or name.

Imprint:
Color:
Shape:

Search by Drug Name

Drug Name:

Search by National Drug Codes (NDC)

NDC:
What is a National Drug Code/NDC Number?

Did you find this page helpful? Yes No

(web4)